60376-73-0

• 常用中文名：methyl 3-[[[(dimethylamino)methylene]amino]sulphonyl]-5-nitro-4-phenoxybenzoate
• 常用英文名：methyl 3-[[[(dimethylamino)methylene]amino]sulphonyl]-5-nitro-4-phenoxybenzoate
• CAS号：60376-73-0
• 分子式：C₁₇H₁₇N₃O₇S
• 分子量：407.39800
• 发布时间：2016-10-20 19:42:51
• 更新时间：2025-08-26 06:36:50

名称

• 英文名: methyl 3-(dimethylaminomethylideneamino)sulfonyl-5-nitro-4-phenoxybenzoate
• 英文别名: methyl 3-({[(dimethylamino)methylene]amino}sulfonyl)-5-nitro-4-phenoxybenzoate; 3-nitro-4-phenoxy-5-N,N-dimethylaminomethyleneaminosulphonyl-benzoic acid methyl ester; 3-(dimethylaminomethylenesulfamoyl)-5-nitro-4-phenoxybenzoic acid methyl ester; Methyl 3-((((dimethylamino)methylene)amino)sulphonyl)-5-nitro-4-phenoxybenzoate

物化性质

• 密度: 1.36g/cm3
• 沸点: 544.9ºC at 760 mmHg
• 分子式: C₁₇H₁₇N₃O₇S
• 分子量: 407.39800
• 闪点: 283.3ºC
• 精确质量: 407.07900
• PSA: 139.47000
• LogP: 4.05630
• 折射率: 1.595

安全

• 海关编码: 2935009090

合成路线

57939-04-5 4637-24-5 ~% 60376-73-0

文献：NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; Location in patent: Page/Page column 111 ; WO 2012/018635 A2

108-95-2 ~% 60376-73-0

文献：NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; WO 2012/018635 A2

22892-96-2 ~% 60376-73-0

文献：NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; WO 2012/018635 A2

28328-53-2 ~% 60376-73-0

文献：NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; WO 2012/018635 A2 Title/Abstract Full Text Show Details NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen, P.; COLLINS, Stephen, D.; KINCAID, John; DODSON, Gary, Steven Patent: WO2013/59648 A1, 2013 ;

海关

海关编码	2935009090
中文概述	2935009090 其他磺（酰）胺. 增值税率:17.0% 退税率:9.0% 监管条件:无 最惠国关税:6.5% 普通关税:35.0%
申报要素	品名, 成分含量, 用途
Summary	2935009090 other sulphonamides VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:35.0%